Article
Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.
Antimicrobial agents and chemotherapy - 1 Feb 2005
Moudgal Varsha, Little Tania, Boikov Dina, Vazquez Jose A
Abstract excerpt
Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)-resistant Candida strain during therapy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
